Digital technology for diabetes

MS Hughes, A Addala… - New England Journal of …, 2023 - Mass Medical Soc
Digital Technology for Diabetes | New England Journal of Medicine Skip to main content The
New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

Expert guidance on off-label use of hybrid closed-loop therapy in pregnancies complicated by diabetes

ED Szmuilowicz, CJ Levy, EO Buschur… - Diabetes Technology & …, 2023 - liebertpub.com
Automated insulin delivery (AID) systems have established benefits in terms of glycemic
control, health outcomes, and quality of life and are strongly recommended for people with …

Real‐world performance of the MiniMed 780G advanced hybrid closed loop system in Latin America: substantial improvement in glycaemic control with each …

B Grassi, AM Gómez, LE Calliari… - Diabetes, Obesity …, 2023 - Wiley Online Library
Aim We studied real‐world performance of MiniMed (MM) 780G system users from
Argentina, Brazil, Colombia and Chile (geographical analysis), and the effect of each …

Safety and efficacy of the Omnipod 5 automated insulin delivery system in adults with type 2 diabetes: from injections to hybrid closed-loop therapy

GM Davis, AL Peters, BW Bode, AL Carlson… - Diabetes …, 2023 - Am Diabetes Assoc
OBJECTIVE Automated insulin delivery (AID) has rarely been studied in adults with type 2
diabetes. We tested the feasibility of using AID for type 2 diabetes with the Omnipod 5 …

Disparities in hemoglobin A1c levels in the first year after diagnosis among youths with type 1 diabetes offered continuous glucose monitoring

A Addala, V Ding, DP Zaharieva, FK Bishop… - JAMA Network …, 2023 - jamanetwork.com
Importance Continuous glucose monitoring (CGM) is associated with improvements in
hemoglobin A 1c (HbA 1c) in youths with type 1 diabetes (T1D); however, youths from …

Continuous glucose monitoring in primary care: understanding and supporting clinicians' use to enhance diabetes care

TK Oser, TL Hall, LM Dickinson, E Callen… - The Annals of Family …, 2022 - Annals Family Med
PURPOSE Diabetes affects approximately 34 million Americans and many do not achieve
glycemic targets. Continuous glucose monitoring (CGM) is associated with improved health …

Effect of diabetes technologies on the fear of hypoglycaemia among people living with type 1 diabetes: a systematic review and meta-analysis

MK Talbo, A Katz, L Hill, TM Peters, JF Yale… - …, 2023 - thelancet.com
Background Fear of hypoglycaemia (FOH) significantly disrupts the daily management of
type 1 diabetes (T1D) and increases the risk of complications. Recent technological …

Effects of continuous glucose monitoring on glycaemic control in type 2 diabetes: a systematic review and network meta‐analysis of randomized controlled trials

J Lu, Z Ying, P Wang, M Fu, C Han… - Diabetes, Obesity and …, 2024 - Wiley Online Library
Aims The aim of this study was to assess the efficacy of continuous glucose monitoring
(CGM) versus self‐monitoring of blood glucose (SMBG) in maintaining glycaemic control …

Glycemic outcomes during early use of the MiniMed™ 780G advanced hybrid closed-loop system with Guardian™ 4 sensor

TL Cordero, Z Dai, A Arrieta, F Niu, M Vella… - Diabetes Technology …, 2023 - liebertpub.com
Background: Safety and significant improvement in overall glycated hemoglobin (A1C) and
percentage of time spent in (TIR), below (TBR), and above (TAR) glucose range were …

Insight into continuous glucose monitoring: from medical basics to commercialized devices

A Chmayssem, M Nadolska, E Tubbs, K Sadowska… - Microchimica Acta, 2023 - Springer
According to the latest statistics, more than 537 million people around the world struggle
with diabetes and its adverse consequences. As well as acute risks of hypo-or hyper …